#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute lymphocytic leukaemia Familial hypertriglyceridaemia Prostate cancer Hepatitis D Acute lymphocytic leukaemia recurrent Autologous haematopoietic stem cell transplant Chorioretinitis Ocular lymphoma Liposarcoma metastatic Polyneuropathy Hepato-lenticular degeneration Stress cardiomyopathy Ischaemic stroke Cardiomyopathy Carcinoid tumour More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Trials in Disease Gaucher’s disease type III – Trials in Disease Pemphigoid Burkitt’s lymphoma – Trials in Disease Congenital generalised lipodystrophy – Trials in Disease Primary immunodeficiency syndrome – Diagnostics Cystic fibrosis – Treatment Kearns-Sayre syndrome – Basic Information Erdheim-Chester disease Osteosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    68Ganota-Anti-Her2 Vhh1 Potassium Chloride Teicoplanin Ds-2325A Human Coagulation Factor X Hydrocortisone Acetate Holcus Lanatus Pollen Extract Cefalexin AZD0022 Leniolisib Phosphate Lisinopril Lauromacrogol 400 Rilzabrutinib Nacystelyn Zoledronic Acid Fluoroethyltyrosine F-18 TRIGLYCERIDES MEDIUM CHAIN Pritelivir OBI-821 Abc-31-116 More therapies…

    Learn about Your Condition

    Sleep disorder Pterygium Craniotomy Indolent systemic mastocytosis Peyronie's disease Deafness Death neonatal Prostatitis Escherichia coli Follicular lymphoma stage II Basal cell carcinoma Haemorrhage prophylaxis HER2 negative breast cancer Naevoid melanoma Polycythaemia vera Cough More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Obesity

  • Study on the Effects of Cholecalciferol and Glycerol on Inflammation in Obese Elderly Patients with Vitamin D Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Colecalciferol
    • Glycerol
    Italy

  • Study of esomeprazole effects on endoscopic sleeve gastroplasty structural integrity in obese patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Esomeprazole
    Italy

  • Study of Semaglutide for Weight Loss in Obesity Patients with Low Response After Bariatric Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Semaglutide
    The Netherlands

  • Study on Levothyroxine and Low-Calorie Diet for Weight Loss in Obese Patients with Subclinical Hypothyroidism or High-Normal TSH Levels

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Levothyroxine Sodium
    • Microcrystalline Cellulose
    Spain

  • Study on Pain Relief After Obesity Surgery Using Esketamine, Dexmedetomidine, and Lidocaine Hydrochloride Monohydrate for Patients Undergoing Obesity Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    • Obesity
    Investigated Drugs:
    • Remifentanil Hydrochloride
    • Dexmedetomidine
    • Esketamine
    Sweden

  • Study on the Effects of Semaglutide and Diet on Physical and Heart Health in Patients with Obesity and Heart Failure

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Heart failure with reduced ejection fraction
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Denmark
Previous Page
1 … 3 4 5 6 7 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!